|
|
Article: Endpoints for lymphatic filariasis programs.(DISPATCHES)
- Article from:
- Emerging Infectious Diseases
- Article date:
- April 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 U.S. National Center for Infectious Diseases. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
*********
Globally, more than 1 billion persons are at risk for lymphatic filariasis (LF), a mosquito-transmitted parasitic infection that causes lymphedema and hydrocele. Transmission of LF can be interrupted by annual mass treatment with drugs that target microfilariae, the ...
Related newspaper, magazine, and journal articles:
|
|
MAPOU, HAITI -- Survivors wait for humanitarian aid in ...
KRT Photos;
May 28, 2004 ;
361 words
... ... STORMS KRT PHOTO BY CARL JUSTE/MIAMI HERALD (SOUTH FLORIDA SUN-SENTINEL OUT) (May 28) MAPOU, HAITI -- Survivors wait for humanitarian aid in Mapou, Haiti, on Friday, May 28, 2004, after storms and flooding inundated the town. (gsb ...
|
|